WW 277 (Lithium Carbonate Extended Release 450 mg)
Pill with imprint WW 277 is Yellow, Round and has been identified as Lithium Carbonate Extended Release 450 mg. It is supplied by West-Ward Pharmaceutical Corporation.
Lithium is used in the treatment of bipolar disorder; mania; schizoaffective disorder and belongs to the drug class antimanic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 450 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WW 277
Lithium Carbonate Extended Release
- Imprint
- WW 277
- Strength
- 450 mg
- Color
- Yellow
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antimanic agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- West-Ward Pharmaceutical Corporation
- National Drug Code (NDC)
- 00143-1277
- Inactive Ingredients
-
alginic acid,
corn starch,
magnesium stearate,
povidone,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about lithium
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 396 Reviews
- Drug class: antimanic agents
- FDA Alerts (1)
Consumer resources
- Patient Information
- Lithium (Advanced Reading)
- Lithium Capsules and Tablets
- Lithium Controlled-Release and Extended-Release Tablets
- Lithium Syrup and Oral Solution
- Other brands
- Eskalith, Lithobid, Eskalith-CR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.